"but many boys diagnosed today and receiving optimal care have good quality of life well into their 20's"
dumbest statement ever.....you're going on ignore after that. THINK before you write stupid statements like that!
You left the part about this being something that might help sick children with no other treatment options
Generally, but not always options that are purchased in large quantity are done so at or near the ask......while calls that are sold in large quantity would be done at or someplace near the bid. Hope this helps.
Reuters article pretty much tells EVERYONE what's about to happen......approval with no bb warning. Great time for the patients, caregivers, ACAD and its shareholders. Only people its not great for is shortsellers. Reuters article drives a stake thru the shorts!
with the growth rate they have the P/E will shrink to about 4-6 in 3 yrs lol
"I don't think heart and lung function endpoints are under consideration at this point so they don't matter". Tripped over your peter on that statement
He or she said:
"To me, when ETP gets APPROVED, SRPT stock will return to the high 40s and low 50s."
I changed the letters in the word "approved" to big caps so you would understand.
Shouldn't effective therapies determine approval? Problem is, the agency that us as in " we the people " our tax dollars their salaries we pay dont really seem to be qualified I mean you know their best person to discuss efficacy is an eye doctor? Don't mean to ruffle any feathers but if it quacks like a duck, waslks like a duck well.........maybe we the people need a SDA ( super drug agency) ? Ya know leave the remedial decisions to the current agency but when we need to think " out of box " call in the big guns? How does that sound?
Wat was it.....spring of 2014? Could've given conditional approval then and treated 100s of exon 51 boys then and now h ad close to 100 weeks of data?